AAP
NVAX icon

Arax Advisory Partners’s Novavax NVAX Stock Holding History

Arax Advisory Partners’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68.4K Buy
7,261
+7,086
+4,049% +$63.5K ﹤0.01% 3020
2026
Q1 		$1.43K Buy
175
+76
+77% +$689 ﹤0.01% 3205
2025
Q4 		$666 Sell
99
-907
-90% -$6.84K ﹤0.01% 3560
2025
Q3 		$8.72K Buy
1,006
+982
+4,092% +$7.64K ﹤0.01% 2661
2025
Q2 		$562 Hold
24
– – ﹤0.01% 2915
2025
Q1 		$154 Buy
+24
New +$198 ﹤0.01% 2609

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Arax Advisory Partners's NVAX Position: Q2 2026 in Review

Arax Advisory Partners increased its Novavax (NVAX) stake by 4,049% in Q2 2026, buying an estimated $63.5K and bringing the position to 7,261 shares worth $68.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3020.

Arax Advisory Partners first reported a position in NVAX in Q1 2025 and has held it in 6 quarters since. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Arax Advisory Partners held 7,261 shares of Novavax worth $68.4K as of Q2 2026.
  • Arax Advisory Partners bought 7,086 Novavax shares in Q2 2026, an estimated $63.5K.
  • Novavax made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3020 holding.
  • Arax Advisory Partners first reported a position in Novavax in Q1 2025 and has held it in 6 quarters since.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.